Schedule 13D ownership disclosure

Eloxx Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 29014R103

Event date: 2019-06-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1
Percent of class
18.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-032480
Form type
SC 13D/A
Filer
Eloxx Pharmaceuticals, Inc.
CIK
CIK 1035354
Filed
Jun 26, 2019
Reporting period
Jun 24, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub